The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Motie, M.
Right arrow Articles by Potempa, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Motie, M.
Right arrow Articles by Potempa, L. A.

The Journal of Immunology, Vol 156, Issue 11 4435-4441, Copyright © 1996 by American Association of Immunologists


ARTICLES

Binding of model soluble immune complexes to modified C-reactive protein

M Motie, S Brockmeier and LA Potempa
Immtech International, Inc., Evanston, IL 60201, USA.

We have identified a binding interaction between a modified form of C- reactive protein (mCRP) and model immune complexes. We have characterized these interactions in terms of their relative affinity, specificity, pH dependence, and recognition site on mCRP. First, binding isotherms were generated for the reaction of immobilized mCRP with heat-aggregated IgG (HAG) which gave an estimate for the value of the dissociation constant, Kd, of 1.6 nM. Second, competitive binding assays were performed using immobilized HAG to determine the relative affinity (IC50) for the interaction between HAG or monomeric IgG and mCRP in the fluid phase. While the binding of HAG to mCRP occurred with high affinity (IC50=0.72 nM), the binding of monomeric IgG to mCRP occurred with >2000-fold lower affinity (IC50>1.66 muM). Third, immune complex binding to immobilized mCRP was studied using defined ratios of horseradish peroxidase and rabbit anti-peroxidase Ab. The binding of these complexes to mCRP was strongly pH dependent, with a maximum at pH 5.5. At this optimal pH, preformed peroxidase-antiperoxidase immune complexes (approximately 2:3 Ab:Ag molar ratio) were shown to bind immobilized mCRP with a Kd of 111 nM. Fourth, using mCRP-specific mAbs, HAG and peroxidase- antiperoxidase binding sites were localized to CRP sequences to 130 to 138 and 200 to 206. Since inflammatory processes often cause microenvironments to become acidic, and since mCRP selectively binds immune complexes at acidic pH, we propose that mCRP mediates the specific binding of immune complexes in vivo and potentiates effector reactions for immune complex removal.


This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
A. Jonsen, I. Gunnarsson, B. Gullstrand, E. Svenungsson, A. A. Bengtsson, O. Nived, I. E. Lundberg, L. Truedsson, and G. Sturfelt
Association between SLE nephritis and polymorphic variants of the CRP and Fc{gamma}RIIIa genes
Rheumatology, September 1, 2007; 46(9): 1417 - 1421.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Khreiss, L. Jozsef, S. Hossain, J. S. D. Chan, L. A. Potempa, and J. G. Filep
Loss of Pentameric Symmetry of C-reactive Protein Is Associated with Delayed Apoptosis of Human Neutrophils
J. Biol. Chem., October 18, 2002; 277(43): 40775 - 40781.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Zouki, B. Haas, J. S. D. Chan, L. A. Potempa, and J. G. Filep
Loss of Pentameric Symmetry of C-Reactive Protein Is Associated with Promotion of Neutrophil-Endothelial Cell Adhesion
J. Immunol., November 1, 2001; 167(9): 5355 - 5361.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. Vaith, L. A. Potempa, J. Torzewski, and M. Torzewski
Deposition of Modified or Native C-Reactive Protein in Atherosclerotic Arteries?
Arterioscler. Thromb. Vasc. Biol., April 1, 2000; 20(4): 1173 - 1174.
[Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
M. Motie, K. W. Schaul, and L. A. Potempa
Biodistribution and Clearance of 125I-Labeled C-Reactive Protein and 125I-Labeled Modified C-Reactive Protein in CD-1 Mice
Drug Metab. Dispos., October 1, 1998; 26(10): 977 - 981.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.